Quick Answer
CASTLE BIOSCIENCES INC reported Cash and Equivalents of $116.73 million for fiscal year 2025.
CASTLE BIOSCIENCES INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $116.73M | -2.5% |
| 2024 | $119.71M | +21.1% |
| 2023 | $98.84M | -19.6% |
| 2022 | $122.95M | -62.7% |
| 2021 | $329.63M | -19.6% |
| 2020 | $409.85M | +314.6% |
| 2019 | $98.84M | +2106.9% |
| 2018 | $4.48M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $85.56M | -9.9% | +4.0% |
| June 30, 2025 | $82.23M | -3.9% | -8.3% |
| March 31, 2025 | $89.69M | +8.1% | -25.1% |
| December 31, 2024 | $119.71M | +21.1% | +26.1% |
| September 30, 2024 | $94.96M | +4.1% | +11.0% |
| June 30, 2024 | $85.57M | -10.7% | +3.2% |
| March 31, 2024 | $82.95M | -27.8% | -16.1% |
| December 31, 2023 | $98.84M | -19.6% | +8.4% |
- CASTLE BIOSCIENCES INC showed a decrease of -2.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2018–2025 period, CASTLE BIOSCIENCES INC’s cash and equivalents has grown by 2506.1% (from $4.48 million to $116.73 million).
- The most recent figure is from CASTLE BIOSCIENCES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: